What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Surgery
His primary areas of investigation include Pulmonary hypertension, Internal medicine, Surgery, Anesthesia and Cardiology.
His research in Pulmonary hypertension intersects with topics in Respiratory disease, Lung, Sildenafil, Placebo and Vascular resistance.
His Placebo study integrates concerns from other disciplines, such as Sitaxentan, Endothelin receptor antagonist and Macitentan.
His Internal medicine study combines topics in areas such as Gastroenterology and Endocrinology.
His studies in Surgery integrate themes in fields like Ambrisentan and Confidence interval.
His research investigates the link between Cardiology and topics such as Bosentan that cross with problems in Prospective cohort study and Hazard ratio.
His most cited work include:
- Sildenafil citrate therapy for pulmonary arterial hypertension. (1945 citations)
- Reversal of experimental pulmonary hypertension by PDGF inhibition. (874 citations)
- Macitentan and morbidity and mortality in pulmonary arterial hypertension. (827 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Pulmonary hypertension, Cardiology, Riociguat and Surgery.
His Internal medicine study combines topics from a wide range of disciplines, such as Placebo and Endocrinology.
Hossein Ardeschir Ghofrani interconnects Anesthesia, Hypoxia, Lung, Pulmonary artery and Pharmacology in the investigation of issues within Pulmonary hypertension.
His Anesthesia research includes themes of Respiratory disease and Iloprost.
His study in Cardiology is interdisciplinary in nature, drawing from both Sildenafil, Blood pressure and Hazard ratio.
The concepts of his Riociguat study are interwoven with issues in Tolerability, Adverse effect and Clinical trial.
He most often published in these fields:
- Internal medicine (77.98%)
- Pulmonary hypertension (60.70%)
- Cardiology (46.33%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (77.98%)
- Cardiology (46.33%)
- Pulmonary hypertension (60.70%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Cardiology, Pulmonary hypertension, Riociguat and In patient.
His Cardiology study frequently draws connections to other fields, such as MEDLINE.
Pharmacology is closely connected to Hypoxia in his research, which is encompassed under the umbrella topic of Pulmonary hypertension.
His Riociguat research is multidisciplinary, incorporating elements of Sildenafil, Endothelin receptor, Post-hoc analysis and Right heart.
His work carried out in the field of Randomized controlled trial brings together such families of science as Adverse effect and Macitentan.
His Clinical endpoint study integrates concerns from other disciplines, such as Placebo and Endothelin receptor antagonist.
Between 2017 and 2021, his most popular works were:
- Identification of rare sequence variation underlying heritable pulmonary arterial hypertension. (136 citations)
- Identification of rare sequence variation underlying heritable pulmonary arterial hypertension. (136 citations)
- Reserve of Right Ventricular-Arterial Coupling in the Setting of Chronic Overload. (60 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Surgery
Hossein Ardeschir Ghofrani mainly investigates Internal medicine, Cardiology, Pulmonary hypertension, Pulmonary artery and Randomized controlled trial.
Hossein Ardeschir Ghofrani performs integrative study on Internal medicine and In patient in his works.
The study incorporates disciplines such as Hemodynamics, Hypoxia and Pharmacology in addition to Pulmonary hypertension.
Hossein Ardeschir Ghofrani has researched Pulmonary artery in several fields, including Fractional area change, Magnetic resonance imaging and Downregulation and upregulation.
His research in Randomized controlled trial focuses on subjects like Confidence interval, which are connected to Macitentan.
His research in Riociguat intersects with topics in Chronic bronchitis, COPD, Vascular resistance and Airway resistance.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
